Dr. Harkiratjit Singh Bhulla, et al. “LOW-DOSE NIVOLUMAB IN ADVANCED SOLID TUMOURS: ACTIVITY, TOXICITY AND THE MISSING COMPARISON WITH STANDARD DOSE”. Journal of Population Therapeutics and Clinical Pharmacology, vol. 32, no. 11, Dec. 2025, pp. 2230-47, https://doi.org/10.67145/fchabf12.